Eisai and Biogen Announce U.S. Availability of LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., October 8, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)  and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced t...

Sharp’s 5G NTN-Compatible LEO Satellite Communication User Terminal Wins the Minister for Internal Affairs and Communications Award at CEATEC AWARD 2025

Makuhari,Chiba, October 8, 2025 - (JCN Newswire via SeaPRwire.com) - Sharp Corporation's 5G NTN-Compatible LEO Satellite Communication User Terminal (*1) has been awarded the Minister for Internal Affairs and Communications Award at CEATEC AWARD 2025. This award recognizes outstanding technolog...